Expertise in
4
conditions

Emilio Alba

Malaga, AN, ES 
Expertise in
4
conditions
Malaga, AN, ES 

Overview

Emilio Alba practices practicing medicine in Malaga, Spain.

Mr. Alba is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, HER2 Negative Breast Cancer, Breast Cancer in Men, and Tissue Biopsy.

He is actively involved in clinical research, co-authoring 83 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Malaga, AN 29010, Spain
Other Locations
Madrid, MD, Spain
Barcelona, CT 08907, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Subjects With Unresectable Locally-advanced or Metastatic HER2+ Breast Cancer (HER2CLIMB-02)
Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Subjects With Unresectable Locally-advanced or Metastatic HER2+ Breast Cancer (HER2CLIMB-02)
Enrollment Status: Active_not_recruiting
Publish Date: July 23, 2026
Intervention Type: Drug
Study Drugs: tucatinib, T-DM1
Study Phase: Phase 3
Phase III Trial Comparing Efficacy and Tolerance of Fulvestrant for 3 Years (y) Combined With Anastrozole 5 y Versus Anastrozole 5 y as Adjuvant Hormonotherapy in Postmenopausal With Early Breast Cancer and Positive Hormone Receptors
Phase III Trial Comparing Efficacy and Tolerance of Fulvestrant for 3 Years (y) Combined With Anastrozole 5 y Versus Anastrozole 5 y as Adjuvant Hormonotherapy in Postmenopausal With Early Breast Cancer and Positive Hormone Receptors
Enrollment Status: Terminated
Publish Date: March 10, 2023
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

83 Total Publications

Optimising prescription for metastatic breast cancer patients through a three-level submaximal exercise test protocol.
Optimising prescription for metastatic breast cancer patients through a three-level submaximal exercise test protocol.
Journal: Disability and rehabilitation
Published: June 25, 2026

Frequently Asked Questions about Emilio Alba

Is Emilio Alba a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Emilio Alba is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Emilio Alba participate in research or clinical trials?

Yes. Emilio Alba has published 83 articles and abstracts on conditions like Breast Cancer. You can view a list of Emilio Alba's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Alba's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile